ATOH8 could inhibit stem cell features of hepatocellular carcinoma cells [19, 20] and EBV-encoded malignant phenotypes of nasopharyngeal carcinoma [21], while promoting cell proliferation and inhibiting apoptosis in CRC cells [22]. This evidence concerns the gene ATOH8 and colorectal carcinoma.